{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:01:58Z","timestamp":1780920118408,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12098-025-05868-1","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:51:02Z","timestamp":1765950662000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Randomised Controlled Trial Comparing Single Maintenance and Reliever Therapy (SMART) with Inhaled Budesonide-Formoterol Combination, Versus Conventional Budesonide and Additional As-Needed Levo-Salbutamol, in Children with Persistent Bronchial Asthma"],"prefix":"10.1007","volume":"93","author":[{"given":"Annie","family":"Basson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-2623","authenticated-orcid":false,"given":"Joseph L.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"5868_CR1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2163\u201396.","journal-title":"Lancet"},{"key":"5868_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02475-6","volume":"24","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li Y, Gao Y, et al. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019. Respir Res. 2023;24:169.","journal-title":"Respir Res"},{"key":"5868_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.823399","volume":"10","author":"D Zhang","year":"2022","unstructured":"Zhang D, Zheng J. The burden of childhood asthma by age group, 1990\u20132019: a systematic analysis of global burden of disease 2019 data. Front Pediatr. 2022;10:823399.","journal-title":"Front Pediatr"},{"key":"5868_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1164\/rccm.201901-0016OC","volume":"200","author":"M Yaghoubi","year":"2019","unstructured":"Yaghoubi M, Adibi A, Safari A, Fitzgerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019;200:1102\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"5868_CR5","unstructured":"Global Initiative for Asthma - GINA. 2021. Available at: https:\/\/ginasthma.org\/. Accessed April 21, 2024."},{"key":"5868_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/jim-2019-001000","volume":"67","author":"F Chau-Etchepare","year":"2019","unstructured":"Chau-Etchepare F, Hoerger JL, Kuhn BT, et al. Viruses and non-allergen environmental triggers in asthma. J Investig Med. 2019;67:1029\u201341.","journal-title":"J Investig Med"},{"key":"5868_CR7","doi-asserted-by":"publisher","first-page":"e42232","DOI":"10.1371\/journal.pone.0042232","volume":"7","author":"Y Guo","year":"2012","unstructured":"Guo Y, Jiang F, Peng L, et al. The association between cold spells and pediatric outpatient visits for asthma in Shanghai, China. PLoS ONE. 2012;7:e42232.","journal-title":"PLoS ONE"},{"key":"5868_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.immunol.17.1.255","volume":"17","author":"M Wills-Karp","year":"1999","unstructured":"Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999;17:255\u201381.","journal-title":"Annu Rev Immunol"},{"key":"5868_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/02770903.2015.1108440","volume":"53","author":"SI Sheikh","year":"2016","unstructured":"Sheikh SI, Pitts J, Ryan-Wenger NA, McCoy KS, Hayes D Jr. Environmental exposures and family history of asthma. J Asthma. 2016;53:465\u201370.","journal-title":"J Asthma"},{"key":"5868_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ppul.1950190302","volume":"19","author":"ST Weiss","year":"1995","unstructured":"Weiss ST, Gold DR. Gender differences in asthma. Pediatr Pulmonol. 1995;19:153\u20135.","journal-title":"Pediatr Pulmonol"},{"key":"5868_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2500\/aap.2014.35.3789","volume":"35","author":"G Ferrante","year":"2014","unstructured":"Ferrante G, Antona R, Malizia V, Montalbano L, Corsello G, La Grutta S. Smoke exposure as a risk factor for asthma in childhood: a review of current evidence. Allergy Asthma Proc. 2014;35:454\u201361.","journal-title":"Allergy Asthma Proc"},{"key":"5868_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02730-2021","volume":"59","author":"HK Reddel","year":"2022","unstructured":"Reddel HK, Bacharier LB, Bateman ED, et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2022;59:2102730.","journal-title":"Eur Respir J"},{"key":"5868_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1183\/09031936.02.00283202","volume":"19","author":"PJ Barnes","year":"2002","unstructured":"Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2- agonists and corticosteroids. Eur Respir J. 2002;19:182\u201391.","journal-title":"Eur Respir J"},{"key":"5868_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.2018.2769","volume":"319","author":"DM Sobieraj","year":"2018","unstructured":"Sobieraj DM, Weeda ER, Nguyen E, et al. Association of inhaled corticosteroids and long-acting \u03b2-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA. 2018;319:1485\u201396.","journal-title":"JAMA"},{"key":"5868_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2015.11.002","volume":"111","author":"R Aalbers","year":"2016","unstructured":"Aalbers R, Vogelmeier C, Kuna P. Achieving asthma control with ICS\/LABA: a review of strategies for asthma management and prevention. Respir Med. 2016;111:1\u20137.","journal-title":"Respir Med"},{"key":"5868_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-022-00690-2","volume":"18","author":"AK Ellis","year":"2022","unstructured":"Ellis AK, Foran V, Kaplan A, Mitchell PD. Clarifying SABA overuse: translating Canadian Thoracic Society guidelines into clinical practice. Allergy Asthma Clin Immunol. 2022;18:48.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"5868_CR17","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","volume":"130","author":"H Bisgaard","year":"2006","unstructured":"Bisgaard H, Le Roux P, Bj\u00e5mer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide\/ formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest. 2006;130:1733\u201343.","journal-title":"Chest"},{"key":"5868_CR18","first-page":"591","volume":"14","author":"VR Parmar","year":"1977","unstructured":"Parmar VR, Kumar L, Malik SK. Normal value of peak expiratory flow rate in healthy North Indian school children, 6\u201316 years of age. Indian Pediatr. 1977;14:591\u20134.","journal-title":"Indian Pediatr"},{"key":"5868_CR19","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American thoracic society And European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200:e70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"key":"5868_CR20","first-page":"24","volume":"38","author":"M Singh","year":"2001","unstructured":"Singh M, Kumar L. Randomized comparison of a dry powder inhaler and metered dose inhaler with spacer in management of children with asthma. Indian Pediatr. 2001;38:24\u20138.","journal-title":"Indian Pediatr"},{"key":"5868_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1081-1206(10)60807-1","volume":"97","author":"GC Jat","year":"2006","unstructured":"Jat GC, Mathew JL, Singh M. Treatment with 400 microg of inhaled budesonide vs. 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. Ann Allergy Asthma Immunol. 2006;97:397\u2013401.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"5868_CR22","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","volume":"337","author":"RA Pauwels","year":"1997","unstructured":"Pauwels RA, L\u00f6fdahl CG, Postma DS, et al. Effect of inhaled formoterol and Budesonide on exacerbations of asthma. Formoterol and corticosteroids Establishing therapy (FACET) international study group. N Engl J Med. 1997;337:1405\u201311.","journal-title":"N Engl J Med"},{"key":"5868_CR23","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.jaip.2021.10.032","volume":"10","author":"BE Chipps","year":"2022","unstructured":"Chipps BE, Murphy KR, Oppenheimer J. 2020 NAEPP guidelines update and GINA 2021-asthma care differences, overlap, and challenges. J Allergy Clin Immunol Pract. 2022;10:S19\u201330.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"5868_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1185\/030079904X2051","volume":"20","author":"R Scicchitano","year":"2004","unstructured":"Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide\/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20:1403\u201318.","journal-title":"Curr Med Res Opin"},{"key":"5868_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","volume":"1","author":"A Papi","year":"2013","unstructured":"Papi A, Corradi M, Pigeon-Francisco C, et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med. 2013;1:23\u201331.","journal-title":"Lancet Respir Med"},{"key":"5868_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1053\/rmed.2003.1504","volume":"97","author":"L Rosenhall","year":"2003","unstructured":"Rosenhall L, Elvstrand A, Tilling B, et al. One-year safety and efficacy of budesonide\/ formoterol in a single inhaler (symbicort turbuhaler) for the treatment of asthma. Respir Med. 2003;97:702\u20138.","journal-title":"Respir Med"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-025-05868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-025-05868-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-025-05868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:36:03Z","timestamp":1769744163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-025-05868-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5868"],"URL":"https:\/\/doi.org\/10.1007\/s12098-025-05868-1","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}